References
- Koob G F, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97–129, [PUBMED], [INFOTRIEVE], [CSA]
- Goeders N E. Stress and cocaine addiction. J Pharmacol Exp Ther 2002; 301: 785–789, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dackis C A, Gold M S. Biological aspects of cocaine addiction. Cocaine in the Brain, N D Volkow. Ritgers University Press, Houston, TX 1988
- Goeders N E, Guerin G F. Non‐contingent electric footshock facilitates the acquisition of intravenous cocaine self‐administration in rats. Psychopharmacology 1994; 114: 63–70, [PUBMED], [INFOTRIEVE]
- Goeders N E, Guerin G F. Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self‐administration in rats. Brain Res 1996; 722: 145–152, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Deroche V, Marinelli M, Le Moal M, Piazza P V. Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self‐administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 1997; 281: 1401–1407, [PUBMED], [INFOTRIEVE], [CSA]
- Goeders N E, Clampitt D M. Potential role for the hypothalamo‐pituitary‐adrenal axis in the conditioned reinforcer‐induced reinstatement of extinguished cocaine seeking in rats. Psychopharmacology (Berl) 2002; 161: 222–232, [CROSSREF], [CSA]
- Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 2003; 168: 3–20, [CROSSREF], [CSA]
- Shalev U, Grimm J W, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 2002; 54: 1–42, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Erb S, Shaham Y, Stewart J. The role of corticotropin‐releasing factor and corticosterone in stress‐ and cocaine‐induced relapse to cocaine seeking in rats. J Neurosci 1998; 18: 5529–5536, [PUBMED], [INFOTRIEVE]
- DeVries A C, Taymans S E, Sundstrom J M, Pert A. Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by corticotropin‐releasing factor. Brain Res 1998; 786: 39–46, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Berger S P, Hall S, Mickalian J D, Reid M S, Crawford C A, Delucchi K, Carr K, Hall S. Haloperidol antagonism of cue‐elicited cocaine craving. Lancet 1996; 347: 504–508, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reid M S, Mickalian J D, Delucchi K L, Hall S M, Berger S P. An acute dose of nicotine enhances cue‐induced cocaine craving. Drug Alcohol Depend 1998; 49: 95–104, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Reid M S, Mickalian J D, Delucchi K L, Berger S P. A nicotine antagonist, mecamylamine, reduces cue‐induced cocaine craving in cocaine‐dependent subjects. Neuropsychopharmacology 1999; 20: 297–307, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lesch K P, Hoh A, Schulte H M, Osterheider M, Muller T. Long‐term fluoxetine treatment decreases 5‐HT1A receptor responsivity in obsessive‐compulsive disorder. Psychopharmacology (Berl) 1991; 105: 415–420, [CSA]
- Jensen J B, Jessop D S, Harbuz M S, Mork A, Sanchez C, Mikkelsen J D. Acute and long‐term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 1999; 11: 465–471, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Peiffer A, Veilleux S, Barden N. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 1991; 16: 505–515, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Batki S L, Washburn A M, Delucchi K, Jones R T. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend 1996; 41: 137–142, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Physician's Desk Reference. Medical Economics Company, Inc., Montvale, NJ 1998
- Robbins S J, Ehrman R N, Childress A R, O'Brien C P. Relationships among physiological and self‐report responses produced by cocaine‐related cues. Addict Behav 1997; 22: 157–167, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hart C L, Jatlow P, Sevarino K A, McCance‐Katz E F. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology (Berl) 2000; 149: 153–162, [CROSSREF], [CSA]
- Childress A R, McLellan A T, O'Brien C P. Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict 1986; 81: 655–660, [PUBMED], [INFOTRIEVE]
- Gawin F H, Kleber H D. Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry 1984; 41: 903–909, [PUBMED], [INFOTRIEVE]
- Jacob P, III, Elias‐Baker B A, Jones R T, Benowitz N L. Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. J Chromatogr 1987; 417: 277–286, [PUBMED], [INFOTRIEVE]
- Murphy B E. Some studies of the protein‐binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein‐binding radioassay. J Clin Endocrinol Metab 1967; 27: 973–990, [PUBMED], [INFOTRIEVE]
- Sinha R, Catapano D, O'Malley S. Stress‐induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl) 1999; 142: 343–351, [CROSSREF]
- Ward A S, Collins E D, Haney M, Foltin R W, Fischman M W. Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans. Behav Pharmacol 1998; 9: 577–586, [PUBMED], [INFOTRIEVE], [CSA]
- Gilbert F S. Development of a “steps questionnaire”. J Stud Alcohol 1991; 52: 353–360, [PUBMED], [INFOTRIEVE]
- Vielva I, Iraurgi I. Cognitive and behavioural factors as predictors of abstinence following treatment for alcohol dependence. Addiction 2001; 96: 297–303, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Miller N S, Gold M S. Dissociation of “conscious desire” (craving) from and relapse in alcohol and cocaine dependence. Ann Clin Psychiatry 1994; 6: 99–106, [PUBMED], [INFOTRIEVE], [CSA]
- Bizot J, Le Bihan C, Puech A J, Hamon M, Thiebot M. Serotonin and tolerance to delay of reward in rats. Psychopharmacology (Berl) 1999; 146: 400–412, [CSA]
- Fairbanks L A, Melega W P, Jorgensen M J, Kaplan J R, McGuire M D. Social impulsivity inversely associated with CSF 5‐HIAA and fluoxetine exposure in vervet monkeys. Psychopharmacology 2001; 24: 370–378
- Alcami Pertejo M, Peral Guerra M, Gilaberte I. Open study of fluoxetine in children with autism. Actas Esp Psiquiatr 2000; 28: 353–356, [PUBMED], [INFOTRIEVE]
- Silva H, Jerez S, Paredes A, Salvo J, Renteria P, Ramirez A, Montes C. Fluoxetine in the treatment of borderline personality disorder. Actas Luso Esp Neurol Psiquiatr Cine Afines 1997; 25: 391–395
- Satel S L, Krystal J H, Delgado P L, Kosten T R, Charney D S. Tryptophan depletion and attenuation of cue‐induced craving for cocaine. Am J Psychiatry 1995; 152: 778–783, [PUBMED], [INFOTRIEVE]
- Wong D T, Bymaster F P, Engleman E A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 1995; 57: 411–441, [CROSSREF]
- Tran‐Nguyen L T, Bellew J G, Grote K A, Neisewander J L. Serotonin depletion attenuates cocaine seeking but enhances sucrose seeking and the effects of cocaine priming on reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 2001; 157: 340–348, [CROSSREF]
- Burmeister J J, Lungren E M, Neisewander J L. Effects of fluoxetine and d‐fenfluramine on cocaine‐seeking behavior in rats. Psychopharmacology (Berl) 2003; 168: 146–154, [CROSSREF]
- Baker D A, Tran‐Nguyen T L, Fuchs R A, Neisewander J L. Influence of individual differences and chronic fluoxetine treatment on cocaine‐seeking behavior in rats. Psychopharmacology (Berl) 2001; 155: 18–26, [CROSSREF]
- Goeders N E, Guerin G F. Role for corticosterone in intravenous cocaine self‐administration in rats. Neuroendocrinology 1996; 64: 337–348, [PUBMED], [INFOTRIEVE], [CSA]
- Shalev U, Marinelli M, Baumann M H, Piazza P V, Shaham Y. The role of corticosterone in food deprivation‐induced reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 2003; 168: 170–176, [CROSSREF], [CSA]
- Pozzi L, Invernizzi R, Garavaglia C, Samanin R. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram. J Neurochem 1999; 73: 1051–1057, [PUBMED], [INFOTRIEVE], [CROSSREF]